Wednesday, January 30, 2008

EFFENTORA : What's in a name?


Recently, our company sent out an email announcing the following:

Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain



A co-worked sent me this comment by email:

That CANNOT be its name!
It sounds like the complaint of the Bar Mitzvah boy!

No comments:

Post a Comment